Access content directly

François Bertucci

404
Documents

Publications

Image document

PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent

Justine Gantzer , Maud Toulmonde , François Séverac , Ali N. Chamseddine , Celine Charon-Barra
Journal articles hal-04533834v1
Image document

Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort

Olivier Trédan , Maud Toulmonde , Christophe Le Tourneau , Laure Montane , Antoine Italiano
Journal articles hal-04209734v1

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer

François Bertucci , Alexandre de Nonneville , Pascal Finetti , Emilie Mamessier
Cancer Communications, 2023, 43 (8), pp.943-946. ⟨10.1002/cac2.12447⟩
Journal articles hal-04390884v1
Image document

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

Alice Mogenet , Pascal Finetti , Emilie Denicolai , Laurent Greillier , Pascaline Boudou-Rouquette
Journal of Translational Medicine, 2023, 21 (1), pp.637. ⟨10.1186/s12967-023-04463-2⟩
Journal articles hal-04390901v1
Image document

PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma

David Jeremie Birnbaum , Maelle Picard , Quentin da Costa , Thomas Delayre , Pascal Finetti
Cancers, 2023, 15 (2), pp.447. ⟨10.3390/cancers15020447⟩
Journal articles hal-03958279v1

RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1

François Bertucci , Alexandre de Nonneville , Pascal Finetti , Emilie Mamessier
JNCI: Journal of the National Cancer Institute, 2023, 115 (6), pp.762-763. ⟨10.1093/jnci/djad060⟩
Journal articles hal-04390880v1

The MonarchE trial: improving the clinical outcome in HR + /HER2 − early breast cancer: recent results and next steps

François Bertucci , Pascal Finetti , Emilie Mamessier , Alexandre de Nonneville
Cancer Communications, 2023, 43 (8), pp.938-942. ⟨10.1002/cac2.12466⟩
Journal articles hal-04390900v1
Image document

Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype

Alexandre de Nonneville , Pascal Finetti , Laurys Boudin , Emilie Denicolaï , Daniel Birnbaum
Pharmaceutics, 2023, 15 (3), pp.938. ⟨10.3390/pharmaceutics15030938⟩
Journal articles hal-04390874v1
Image document

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

Alice Mogenet , Pascal Finetti , Emilie Denicolai , Laurent Greillier , Pascaline Boudou-Rouquette
Journal of Translational Medicine, 2023, 21 (1), pp.637. ⟨10.1186/s12967-023-04463-2⟩
Journal articles hal-04390234v1

Timing evolution of lobular breast cancer through phylogenetic analysis

Danai Fimereli , David Venet , Mattia Rediti , Bram Boeckx , Marion Maetens
EBIOMEDICINE, 2022, 82, ⟨10.1016/j.ebiom.2022.104169⟩
Journal articles hal-04084988v1

Évolution et facteurs associés à la publication des travaux de thèse d’exercice par les internes d’oncologie médicale en France

Alexandre de Nonneville , F. Bertucci , Éric Lambaudie , Gilles Houvenaeghel , Renaud Sabatier
Bulletin du Cancer, 2022, ⟨10.1016/j.bulcan.2022.01.009⟩
Journal articles hal-03623519v1

Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease

Alban Macagno , Alexandre De Nonneville , Pierre Annede , Gilles Piana , Isabelle Pougnet
CURRENT ONCOLOGY, 2022, 29 (3), pp.1683-1694. ⟨10.3390/curroncol29030140⟩
Journal articles hal-04085333v1

RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis

Alexandre de Nonneville , Pascal Finetti , Emilie Mamessier , François Bertucci
JNCI: Journal of the National Cancer Institute, 2022, ⟨10.1093/jnci/djac031⟩
Journal articles hal-03583244v1

Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression

Victoire Gouirand , Tristan Gicquel , Evan Lien , Emilie Jaune‐pons , Quentin da Costa
EMBO Journal, 2022, ⟨10.15252/embj.2021110466⟩
Journal articles hal-03623502v1

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC

Charlotte Rypens , F. Bertucci , Pascal Finetti , Fredika Robertson , Sandra Fernandez
npj Breast Cancer, 2022, 8 (1), pp.12. ⟨10.1038/s41523-021-00379-6⟩
Journal articles hal-03623626v1
Image document

Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients

Alexia Lopresti , Claire Acquaviva , Laurys Boudin , Pascal Finetti , Séverine Garnier
Cancers, 2022, 14 (4), pp.932. ⟨10.3390/cancers14040932⟩
Journal articles hal-03583233v1

Pathological complete response rate and disease-free survival after neoadjuvant chemotherapy in patients with HER2-low and HER2-0 breast cancers

Alexandre De Nonneville , Gilles Houvenaeghel , Monique Cohen , Laura Sabiani , Marie Bannier
European Journal of Cancer, 2022, 176, pp.181-188. ⟨10.1016/j.ejca.2022.09.017⟩
Journal articles hal-04084964v1
Image document

MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer

Maroua Manai , Ines Elbini-Dhouib , Pascal Finetti , Haifa Bichiou , Carolina Reduzzi
Cells, 2022, 11 (18), pp.2926. ⟨10.3390/cells11182926⟩
Journal articles hal-03958360v1

A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer

Chang Gong , Ziliang Cheng , Yaping Yang , Jun Shen , Yingying Zhu
SCIENCE CHINA-LIFE SCIENCES, 2022, 65 (11), pp.2205-2217. ⟨10.1007/s11427-022-2104-3⟩
Journal articles hal-04085305v1
Image document

CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response

Laurys Boudin , A de Nonneville , Pascal Finetti , Léna Mescam , A Le Cesne
Journal of Translational Medicine, 2022, 20 (1), pp.464. ⟨10.1186/s12967-022-03679-y⟩
Journal articles hal-03958345v1

Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group

Pascaline Boudou‐rouquette , Elodie Martin , Emmanuelle Kempf , Nicolas Penel , Maud Toulmonde
International Journal of Cancer, 2022, 150 (5), pp.825-836. ⟨10.1002/ijc.33837⟩
Journal articles hal-03560233v1

Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial

Émilien Billon , Gwenaelle Gravis , Arnaud Guille , Nadine Carbuccia , José Adélaïde
Cancers, 2022, 14 (9), ⟨10.3390/cancers14092275⟩
Journal articles hal-04085310v1

EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer

Xiaoping Wang , Takashi Semba , Ganiraju C. Manyam , Jing Wang , Shan Shao
Science Advances , 2022, 8 (50), ⟨10.1126/sciadv.abn7983⟩
Journal articles hal-04084958v1

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Yi Xiao , Ding Ma , Yun-Song Yang , Fan Yang , Jia-Han Ding
Journal articles hal-03623509v1
Image document

TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT

Alexandre de Nonneville , Sébastien Salas , François Bertucci , Alexander P Sobinoff , José Adélaïde
EMBO Molecular Medicine, 2022, 14, ⟨10.15252/emmm.202215859⟩
Journal articles hal-03877721v1

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells

Violette Azzoni , Julien Wicinski , Manon Macario , Martin Castagné , Pascal Finetti
Cell Death and Disease, 2022, 13 (2), pp.96. ⟨10.1038/s41419-022-04538-w⟩
Journal articles hal-03623505v1
Image document

Loss of primary cilia promotes inflammation and carcinogenesis

Conception Paul , Ruizhi Tang , Ciro Longobardi , Rossano Lattanzio , Thibaut Eguether
EMBO Reports, 2022, ⟨10.15252/embr.202255687⟩
Journal articles hal-03856745v1
Image document

Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study

Renaud Sabatier , Cécile Vicier , Séverine Garnier , Arnaud Guille , Nadine Carbuccia
Molecular Oncology, 2022, 16 (10), pp.2057-2070. ⟨10.1002/1878-0261.13188⟩
Journal articles hal-03583253v1
Image document

Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients

Alexia Lopresti , Claire Acquaviva , Laurys Boudin , Pascal Finetti , Séverine Garnier
Cancers, 2022, 14 (4), pp.932. ⟨10.3390/cancers14040932⟩
Journal articles hal-03637735v1
Image document

Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)

C. Moreau-Bachelard , L. Campion , M. Toulmonde , A. Le Cesne , M. Brahmi
ESMO Open, 2022, 7 (2), pp.100402. ⟨10.1016/j.esmoop.2022.100402⟩
Journal articles hal-03623511v1

Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity

Chaïma Cherif , Dang Tan Nguyen , Clément Paris , Thi Khanh Le , Thibaud Sefiane
Oncogene, 2022, 41 (1), pp.125-137. ⟨10.1038/s41388-021-02039-2⟩
Journal articles hal-03599176v1
Image document

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors

Justine Gantzer , Guillaume Davidson , Bujamin Vokshi , Noëlle Weingertner , Antoine Bougoüin
Journal articles hal-03623495v1

CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response

Alexandre De Nonneville , Pascal Finetti , Maelle Picard , Audrey Monneur , Maria Abbondanza Pantaleo
Cancers, 2022, 14 (5), ⟨10.3390/cancers14051306⟩
Journal articles hal-04085332v1
Image document

No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?

Yohan Fayet , Christine Chevreau , Gauthier Decanter , Cécile Dalban , Pierre Méeus
Cancers, 2022, 14 (11), pp.2620. ⟨10.3390/cancers14112620⟩
Journal articles hal-03718397v1
Image document

CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression

Laurys Boudin , Alexandre de Nonneville , Pascal Finetti , Geoffrey Guittard , Jacques Nunes
Cancers, 2022, 14 (14), pp.3356. ⟨10.3390/cancers14143356⟩
Journal articles hal-03765362v1
Image document

Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy

Mathias Neron , Arnaud Guille , Lucie Allègre , Pierre-Emmanuel Colombo , Cristina Marinella Leaha
Journal of Personalized Medicine, 2022, 12 (5), pp.655. ⟨10.3390/jpm12050655⟩
Journal articles hal-03765663v1
Image document

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature

Francois Bertucci , Vincent Niziers , Alexandre de Nonneville , Pascal Finetti , Léna Mescam
Journal for Immunotherapy of Cancer, 2022, 10 (1), pp.e003687. ⟨10.1136/jitc-2021-003687⟩
Journal articles hal-03583256v1

First-in-Human, Phase I Study of PCA062 in Solid Tumors—Letter

Bernadette de Rauglaudre , Pascal Finetti , David Jérémie Birnbaum , Marc Lopez , François Bertucci
Molecular Cancer Therapeutics, 2022, 21 (11), pp.1742-1743. ⟨10.1158/1535-7163.MCT-22-0240⟩
Journal articles hal-03958336v1

TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients

Cecile Vicier , Patrick Sfumato , Nicolas Isambert , Florence Dalenc , Marie Robert
European Journal of Cancer, 2021, 159, pp.205-214. ⟨10.1016/j.ejca.2021.09.040⟩
Journal articles hal-03622797v1
Image document

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

P. Pautier , A. Floquet , C. Chevreau , N. Penel , C. Guillemet
ESMO Open, 2021, 6 (4), pp.100209. ⟨10.1016/j.esmoop.2021.100209⟩
Journal articles hal-03623631v1
Image document

Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)

D. Dano , A. Lardy-Cleaud , A. Monneur , N. Quenel-Tueux , C. Levy
ESMO Open, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩
Journal articles hal-03426433v1
Image document

Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy

Gayathri Devi , Pascal Finetti , Michael Morse , Seayoung Lee , Alexandre de Nonneville
Cancers, 2021, 13 (11), pp.2807. ⟨10.3390/cancers13112807⟩
Journal articles hal-03623076v1

Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer

Yuchen Guo , Monica Gabola , Rossano Lattanzio , Conception Paul , Valérie Pinet
Journal of Clinical Investigation, 2021, 131 (4), ⟨10.1172/JCI131517⟩
Journal articles hal-03152320v1

The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer

Anthony Goncalves , Pascal Finetti , Daniel Birnbaum , F. Bertucci
npj Breast Cancer, 2021, 7 (1), pp.48. ⟨10.1038/s41523-021-00256-2⟩
Journal articles hal-03623055v1

739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial

Renaud Sabatier , Cécile Vicier , Séverine Garnier , Arnaud Guille , Nadine Carbuccia
Annals of Oncology, 2021, 32 (15_suppl), pp.S737-S738. ⟨10.1016/j.annonc.2021.08.1181⟩
Journal articles hal-03622737v1

Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma

David Birnbaum , Sebastian K.S. Begg , Pascal Finetti , Charles Vanderburg , Anupriya Kulkarni
Clinical Cancer Research, 2021, 27 (8), pp.2314-2325. ⟨10.1158/1078-0432.CCR-20-1039⟩
Journal articles hal-03623108v1
Image document

Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components

Jean-Luc Raoul , Marie-Françoise Heymann , Frédéric Dumont , Alain Morel , Hélène Senellart
Frontiers in Oncology, 2021, 11, ⟨10.3389/fonc.2021.646992⟩
Journal articles hal-03623095v1

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion

Emilly Villodre , Xiaoding Hu , Richard Larson , Pascal Finetti , Kristen Gomez
Molecular Oncology, 2021, 15 (10), pp.2752-2765. ⟨10.1002/1878-0261.13074⟩
Journal articles hal-03623121v1
Image document

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

Florence Duffaud , Antoine Italiano , Emannuelle Bompas , Maria Rios , Nicolas Penel
European Journal of Cancer, 2021, 150, pp.108-118. ⟨10.1016/j.ejca.2021.03.039⟩
Journal articles hal-03623638v1

Circulating tumor DNA as a noninvasive marker of resectability in ovarian carcinomas.

Roxane Mari , Christophe Pomel , Pierre-Emmanuel Colombo , Fabrice Narducci , Séverine Garnier
Journal of Clinical Oncology, 2021, 39 (15_suppl), pp.5548-5548. ⟨10.1200/JCO.2021.39.15_suppl.5548⟩
Journal articles hal-03622754v1

CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment

Jean-Emmanuel Kurtz , Xavier Buy , Frédéric Deschamps , Erik Sauleau , Amine Bouhamama
European Journal of Cancer, 2021, 143, pp.78-87. ⟨10.1016/j.ejca.2020.10.035⟩
Journal articles hal-03623642v1

WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer

Alexandre Nonneville , Pascal Finetti , Daniel Birnbaum , Emilie Mamessier , François Bertucci
Advanced Science, 2021, 8 (17), pp.2101030. ⟨10.1002/advs.202101030⟩
Journal articles hal-03583269v1

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets

Yue Gong , Peng Ji , Yun-Song Yang , Shao Xie , Tian-Jian Yu
Cell Metabolism, 2021, 33 (1), pp.51-64.e9. ⟨10.1016/j.cmet.2020.10.012⟩
Journal articles hal-03623115v1
Image document

Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion

Stéphane Fattori , Laurent Gorvel , Samuel Granjeaud , Philippe Rochigneux , Marie-Sarah Rouvière
Cancers, 2021, 13 (3), pp.441. ⟨10.3390/cancers13030441⟩
Journal articles hal-03152759v1
Image document

Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment

Dang Tan Nguyen , Thi Khanh Le , Clément Paris , Chaïma Cherif , Stéphane Audebert
Biomedicines, 2021, 9 (7), pp.795. ⟨10.3390/biomedicines9070795⟩
Journal articles hal-03599175v1

Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study

Almudena Callejo , Sara Faouzi , Olivier Bouché , F. Bertucci , Thomas Chevalier
Targeted Oncology, 2021, 16 (4), pp.485-492. ⟨10.1007/s11523-021-00820-7⟩
Journal articles hal-03623633v1
Image document

A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans

Julie Delyon , Raphael Porcher , Maxime Battistella , Nicolas Meyer , Henri Adamski
Journal of Investigative Dermatology, 2021, 141 (4), pp.761-769.e2. ⟨10.1016/j.jid.2020.06.039⟩
Journal articles hal-03623658v1
Image document

Determinants of the access to remote specialised services provided by national sarcoma reference centres

Yohan Fayet , Raphaël Tétreau , Charles Honoré , Louis-Romée Le Nail , Cécile Dalban
BMC Cancer, 2021, 21 (1), pp.631. ⟨10.1186/s12885-021-08393-4⟩
Journal articles inserm-03243378v1
Image document

Case report: Two cases of metastatic pancreatoblastoma in adults: efficacy of Folfirinox and implication of the wnt/β-catenin pathway in genomic analysis

Jean-Luc Raoul , Sandrine Oziel-Taieb , Thierry Lecomte , José Adelaide , Arnaud Guille
Frontiers in Oncology, 2021, 11, pp.1-8. ⟨10.3389/fonc.2021.564506⟩
Journal articles hal-03623119v1
Image document

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

François Bertucci , Anthony Gonçalves , Arnaud Guille , José Adelaïde , Séverine Garnier
Genome Medicine, 2021, 13 (1), pp.87. ⟨10.1186/s13073-021-00897-9⟩
Journal articles hal-03583277v1

Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial

Ke-Da Yu , Xi-Yu Liu , Li Chen , Miao Mo , Jiong Wu
The Lancet Regional Health - Western Pacific, 2021, 11, pp.100158. ⟨10.1016/j.lanwpc.2021.100158⟩
Journal articles hal-03623636v1
Image document

LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma.

Angélina Acier , Magali Godard , Fanny Gassiot , Pascal Finetti , Marion Rubis
Communications Biology, 2021, 4 (1), pp.987. ⟨10.1038/s42003-021-02508-0⟩
Journal articles hal-03452855v1
Image document

The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Christophe van Berckelaer , Iris Vermeiren , Leonie Vercauteren , Charlotte Rypens , Gizem Oner
Cancers, 2021, 13 (18), pp.4656. ⟨10.3390/cancers13184656⟩
Journal articles hal-03623094v1
Image document

CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM

Guillaume Belthier , Zeinab Homayed , Fanny Grillet , Christophe Duperray , Julie Vendrell
Cancers, 2021, 13 (19), pp.4966. ⟨10.3390/cancers13194966⟩
Journal articles hal-03394453v1

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

François Bertucci , Laurys Boudin , Pascal Finetti , Christophe van Berckelaer , Peter van Dam
OncoImmunology, 2021, 10 (1), ⟨10.1080/2162402X.2021.1929724⟩
Journal articles hal-03583271v1

Alpelisib and fulvestrant efficacy in HR-positive HER2-negative PIK3CA -mutant advanced breast cancer: Data from the French early access program.

F. Bertucci , Diana Bello , Alexandre Bertucci , Thibault de La Motte Rouge , Cyriac Blonz
Journal of Clinical Oncology, 2021, 39 (15_suppl), pp.1064-1064. ⟨10.1200/JCO.2021.39.15_suppl.1064⟩
Journal articles hal-03623116v1
Image document

EFA6B regulates a stop signal for collective invasion in breast cancer

Racha Fayad , Monserrat Vázquez Rojas , Mariagrazia Partisani , Pascal Finetti , Shiraz Dib
Nature Communications, 2021, 12, pp.2198. ⟨10.1038/s41467-021-22522-4⟩
Journal articles hal-03434635v1

A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)

P. Pautier , N. Penel , I. Ray-Coquard , A. Italiano , E. Bompas
European Journal of Cancer, 2020, 125, pp.31-37. ⟨10.1016/j.ejca.2019.10.028⟩
Journal articles hal-02429038v1
Image document

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma

Maud Maillard , Christine Chevreau , Félicien Le Louedec , Manon Cassou , Caroline Delmas
Cancers, 2020, 12 (12), pp.3647. ⟨10.3390/cancers12123647⟩
Journal articles hal-03623645v1
Image document

Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions

Evodie Peperstraete , Clément Lecerf , Jordan Collette , Constance Vennin , Ludivine Raby
Cancers, 2020, 12 (7), pp.1730. ⟨10.3390/cancers12071730⟩
Journal articles hal-02896573v1

Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer

François Richard , Samira Majjaj , David Venet , Françoise Rothé , Julien Pingitore
Clinical Cancer Research, 2020, 26 (23), pp.6254-6265. ⟨10.1158/1078-0432.ccr-20-2268⟩
Journal articles hal-03623659v1

The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype

François Bertucci , Pascal Finetti , Anthony Goncalves , Daniel Birnbaum
npj Breast Cancer, 2020, 6 (1), pp.8. ⟨10.1038/s41523-020-0151-5⟩
Journal articles hal-03623676v1

Neoplastic–Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer

Kim Honselmann , Pascal Finetti , David Birnbaum , Christian Monsalve , Ulrich Wellner
Molecular Cancer Research, 2020, 18 (12), pp.1889-1902. ⟨10.1158/1541-7786.mcr-20-0439⟩
Journal articles hal-03623660v1

Publisher Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations

A. Takedachi , E. Despras , S. Scaglione , R. Guérois , J. Guervilly
Nature Structural and Molecular Biology, 2020, 27 (6), pp.604-604. ⟨10.1038/s41594-020-0447-z⟩
Journal articles hal-02997075v1
Image document

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies

Maud Toulmonde , Carlo Lucchesi , Stéphanie Verbeke , Amandine Crombe , Julien Adam
EBioMedicine, 2020, 62, ⟨10.1016/j.ebiom.2020.103131⟩
Journal articles hal-03034609v1

Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations

François Bertucci , Steven Van Laere , Daniel Birnbaum
Oncoscience, 2020, 7 (7-8), pp.57-59. ⟨10.18632/oncoscience.515⟩
Journal articles hal-03623667v1
Image document

Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?

Anaïs Aulas , Pascal Finetti , Shawn Lyons , François Bertucci , Daniel Birnbaum
Cancers, 2020, 12 (9), pp.2470. ⟨10.3390/cancers12092470⟩
Journal articles hal-03606494v1
Image document

SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations

A. Takedachi , E. Despras , S. Scaglione , R. Guérois , J. Guervilly
Nature Structural and Molecular Biology, 2020, 27 (5), pp.438-449. ⟨10.1038/s41594-020-0419-3⟩
Journal articles hal-03079782v1
Image document

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer

Alexandre Bertucci , F. Bertucci , Christophe Zemmour , Florence Lerebours , Jean-Yves Pierga
Frontiers in Oncology, 2020, 10, ⟨10.3389/fonc.2020.575978⟩
Journal articles hal-03623650v1

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers

François Bertucci , Charlotte Rypens , Pascal Finetti , Arnaud Guille , José Adélaïde
Molecular Oncology, 2020, 14 (3), pp.504-519. ⟨10.1002/1878-0261.12621⟩
Journal articles hal-03623678v1
Image document

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting

Bérengère Dadone-Montaudié , Audrey Laroche-Clary , Aline Mongis , Emmanuel Chamorey , Ilaria Di Mauro
Journal articles hal-03034592v1
Image document

PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?

Anthony Gonçalves , Alexandre Bertucci , François Bertucci
Cancers, 2020, 12 (6), pp.1378. ⟨10.3390/cancers12061378⟩
Journal articles hal-03623672v1

Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer—Letter

David Birnbaum , Pascal Finetti , Daniel Birnbaum , F. Bertucci
Clinical Cancer Research, 2020, 26 (20), pp.5539-5539. ⟨10.1158/1078-0432.ccr-20-1969⟩
Journal articles hal-03623653v1

Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity

Charlotte Rypens , Melike Marsan , Christophe van Berckelaer , Charlotte Billiet , Kirsten Melis
Breast Cancer Research and Treatment, 2020, 180 (2), pp.385-395. ⟨10.1007/s10549-020-05571-z⟩
Journal articles hal-03623677v1
Image document

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

Toshiaki Iwase , Kenichi Harano , Hiroko Masuda , Kumiko Kida , Kenneth R Hess
BMC Cancer, 2020, 20 (1), pp.430. ⟨10.1186/s12885-020-06940-z⟩
Journal articles inserm-02913696v1

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Nicolas Penel , Olivier Mir , Jennifer Wallet , Isabelle Ray-Coquard , Axel Le Cesne
European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩
Journal articles hal-03623680v1

Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study

Mathias Neron , Christophe Sajous , Simon Thezenas , Sophie Piperno-Neumann , Fabien Reyal
Annals of Surgical Oncology, 2020, 27 (6), pp.1818-1827. ⟨10.1245/s10434-020-08217-y⟩
Journal articles hal-03623684v1

Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results

Anthony Goncalves , Essia Mezni , F. Bertucci
Current Opinion in Oncology, 2020, 32 (6), pp.585-593. ⟨10.1097/cco.0000000000000680⟩
Journal articles hal-03623648v1
Image document

New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?

Essia Mezni , Cécile Vicier , Mathilde Guerin , Renaud Sabatier , François Bertucci
Cancers, 2020, 12 (6), pp.1573. ⟨10.3390/cancers12061573⟩
Journal articles hal-03623669v1
Image document

Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?

Anaïs Aulas , Pascal Finetti , Shawn M Lyons , François Bertucci , Daniel Birnbaum
Cancers, 2020, 12 (9), pp.2470. ⟨10.3390/cancers12092470⟩
Journal articles hal-02958029v1
Image document

ERBB2b mRNA isoform encodes a nuclear variant of the ERBB2 oncogene in breast cancer

Guoqiang Hua , Aurélie Bergon , Pierre Cauchy , Brigitte Kahn‐perlès , François Bertucci
Journal of Cellular Biochemistry, 2020, ⟨10.1002/jcb.29762⟩
Journal articles hal-02897104v1
Image document

Santé numérique et « cancer hors les murs », Big Data et intelligence artificielle

Francois Bertucci , Anne-Gaëlle Le Corroller-Soriano , Audrey Monneur , Sylvain Fluzin , Patrice Viens
Bulletin du Cancer, 2020, 107 (1), pp.102-112. ⟨10.1016/j.bulcan.2019.07.006⟩
Journal articles hal-02505031v1
Image document

Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC

Mabrouka Doghman-Bouguerra , Pascal Finetti , Nelly Durand , Ivy Zortéa S Parise , Silviu Sbiera
Journal articles inserm-02508381v1
Image document

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

Renaud Sabatier , Emmanuelle Charafe-Jauffret , Jean-Yves Pierga , Hervé Curé , Eric Lambaudie
Journal of Clinical Medicine Research, 2019, 8 (5), pp.612. ⟨10.3390/jcm8050612⟩
Journal articles hal-02145624v1
Image document

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review

Gabrielle Planes-Laine , Philippe Rochigneux , François Bertucci , Anne-Sophie Chrétien , Patrice Viens
Cancers, 2019, 11 (7), pp.1033. ⟨10.3390/cancers11071033⟩
Journal articles hal-02533030v1

Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B

Lorène Seguin , Max Chaffanet , Séverine Garnier , José Adélaïde , Nadine Carbuccia
JCO precision oncology, 2019, 3, pp.1-9. ⟨10.1200/po.18.00362⟩
Journal articles hal-03623688v1

MARCKS protein overexpression is associated with poor prognosis in male breast cancer

Maroua Manai , Syrine Abdeljaoued , Aïda Goucha , Olfa Adouni , Ilhem Bettaieb
Cancer Biomarkers, 2019, 26 (4), pp.513-522. ⟨10.3233/CBM-190637⟩
Journal articles hal-02530358v1

Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin

Alexandre De Nonneville , Dominique Barbolosi , Maeva Andriantsoa , Raouf El-Cheikh , Florence Duffaud
Contemporary Southeast Asia, 2019, 11 (3), pp.432. ⟨10.3390/cancers11030432⟩
Journal articles hal-02461464v1

Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study

Mathias Neron , Christophe Sajous , Simon Thezenas , Sophie Piperno-Neumann , Fabien Reyal
Annals of Surgical Oncology, 2019, ⟨10.1245/s10434-019-08097-x⟩
Journal articles hal-02530556v1
Image document

Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors

David Birnbaum , François Bertucci , Pascal Finetti , Daniel Birnbaum , Emilie Mamessier
Cancers, 2019, 11 (4), pp.497. ⟨10.3390/cancers11040497⟩
Journal articles hal-03583447v1
Image document

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease

Roxane Mari , Emilie Mamessier , Eric Lambaudie , Magali Provansal , Daniel Birnbaum
Cancers, 2019, 11 (6), pp.774. ⟨10.3390/cancers11060774⟩
Journal articles hal-03606425v1

PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target

Francois Bertucci , Pascal Finetti , Audrey Monneur , Delphine Perrot , Christine Chevreau
Molecular Oncology, 2019, 13 (7), pp.1577-1588. ⟨10.1002/1878-0261.12522⟩
Journal articles hal-02504850v1
Image document

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

C. van Berckelaer , C. Rypens , P. van Dam , L. Pouillon , M. Parizel
Breast Cancer Research, 2019, 21 (1), pp.28. ⟨10.1186/s13058-019-1108-1⟩
Journal articles hal-02533387v1
Image document

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma

Emilien Billon , Pascal Finetti , Alexandre Bertucci , Patricia Niccoli , Daniel Birnbaum
OncoImmunology, 2019, 8 (11), pp.e1655362. ⟨10.1080/2162402X.2019.1655362⟩
Journal articles hal-02509464v1

Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution

Luc Xerri , José Adelaïde , Morgan Avenin , Arnaud Guille , Sébastien Taix
Histopathology, 2019, 74 (4), pp.654-662. ⟨10.1111/his.13783⟩
Journal articles hal-02533424v1

Sensitive and easy screening for circulating tumor cells by flow cytometry

Alexia Lopresti , Fabrice Malergue , François Bertucci , Maria Lucia Liberatoscioli , Séverine Garnier
JCI Insight, 2019, 4 (14), ⟨10.1172/jci.insight.128180⟩
Journal articles hal-02529764v1

Author Correction: Genomic characterization of metastatic breast cancers

Francois Bertucci , Charlotte Ng , Anne Patsouris , Nathalie Droin , Salvatore Piscuoglio
Nature, 2019, 572 (7767), pp.E7-E7. ⟨10.1038/s41586-019-1380-3⟩
Journal articles hal-02504834v1
Image document

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study

A. Le Cesne , P. Marec-Berard , J.-Y. Blay , N. Gaspar , F. Bertucci
European Journal of Cancer, 2019, 119, pp.151-157. ⟨10.1016/j.ejca.2019.07.018⟩
Journal articles hal-02529696v1

Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study

Sophie Piperno-Neumann , Isabelle Ray-Coquard , Bob-Valéry Occean , Valérie Laurence , Didier Cupissol
International Journal of Cancer, 2019, 146 (2), pp.413-423. ⟨10.1002/ijc.32526⟩
Journal articles hal-02530602v1

Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients

C. Honore , J.B. Delhorme , E. Nassif , M. Faron , G. Ferron
Surgical Oncology, 2019, 29, pp.107-112. ⟨10.1016/j.suronc.2019.04.002⟩
Journal articles hal-02528457v1

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma

Emilien Billon , Pascal Finetti , Alexandre Bertucci , Patricia Niccoli , Daniel Birnbaum
OncoImmunology, 2019, 8 (11), pp.e1655362. ⟨10.1080/2162402X.2019.1655362⟩
Journal articles hal-03606482v1
Image document

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease

Roxane Mari , Emilie Mamessier , Eric Lambaudie , Magali Provansal , Daniel Birnbaum
Cancers, 2019, 11 (6), pp.774. ⟨10.3390/cancers11060774⟩
Journal articles hal-02152656v1

Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group

Marie Meurer , A. Floquet , I Ray-Coquard , F. Bertucci , M Auriche
International Journal of Gynecological Cancer, 2019, 29 (4), pp.691-698. ⟨10.1136/ijgc-2018-000064⟩
Journal articles hal-02530373v1
Image document

Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on “Cancer outside the Hospital Walls”

Francois Bertucci , Anne-Gaëlle Le Corroller-Soriano , Audrey Monneur-Miramon , Jean-François Moulin , Sylvain Fluzin
Cancers, 2019, 11 (2), pp.219. ⟨10.3390/cancers11020219⟩
Journal articles hal-02504845v1
Image document

A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells

Abir Arfaoui , Claire Rioualen , Violette Azzoni , Guillaume Pinna , Pascal Finetti
EMBO Molecular Medicine, 2019, 11 (10), pp.e9930. ⟨10.15252/emmm.201809930⟩
Journal articles hal-02539524v1

High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer

Renaud Sabatier , Marc Lopez , Arnaud Guille , Emilien Billon , Nadine Carbuccia
JCO precision oncology, 2019, 3, pp.1-8. ⟨10.1200/po.18.00310⟩
Journal articles hal-03623686v1
Image document

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers

Alexandre de Nonneville , Pascal Finetti , José Adelaïde , Eric Lambaudie , Patrice Viens
Cancers, 2019, 11 (8), pp.1158. ⟨10.3390/cancers11081158⟩
Journal articles hal-02518929v1
Image document

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer

Luc Camoin , Jean-Paul Borg , Avais M Daulat , Pascal Finetti , Diego R Revinski
British Journal of Cancer, 2019, 120 (9), pp.931-940. ⟨10.1038/s41416-019-0448-z⟩
Journal articles hal-02145896v1
Image document

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma

David Jérémie Birnbaum , Pascal Finetti , Daniel Birnbaum , Emilie Mamessier , Francois Bertucci
Journal of Clinical Medicine, 2019, 8 (5), pp.596. ⟨10.3390/jcm8050596⟩
Journal articles hal-02509509v1

Genomic characterization of metastatic breast cancers

Francois Bertucci , Charlotte Ng , Anne Patsouris , Nathalie Droin , Salvatore Piscuoglio
Nature, 2019, 569 (7757), pp.560-564. ⟨10.1038/s41586-019-1056-z⟩
Journal articles hal-02504838v1
Image document

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases

Marguerite Tyran , Nadine Carbuccia , Séverine Garnier , Arnaud Guille , José Adelaïde
Cancers, 2019, 11 (5), pp.665. ⟨10.3390/cancers11050665⟩
Journal articles hal-02533361v1

Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer

Maroua Manai , Raoudha Doghri , Pascal Finetti , Karima Mrad , Rihab Bouabsa
In Vivo, 2019, 34 (1), pp.177-184. ⟨10.21873/invivo.11759⟩
Journal articles hal-03623682v1

Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour

Alexandre Bertucci , Jérôme Guiramand , Lena Mescam , Audrey Monneur , Magali Bisbal
Case Reports in Oncology, 2019, 12 (2), pp.644-649. ⟨10.1159/000502338⟩
Journal articles hal-02504820v1

Pathological grade-independent prediction of chemosensitivity by CINSARC should rehabilitate adjuvant chemotherapy in soft tissue sarcomas of any grade

F. Bertucci , P. Finetti , A. Monneur , D. Birnbaum
Annals of Oncology, 2019, 30 (2), pp.342-343. ⟨10.1093/annonc/mdy528⟩
Journal articles hal-02505000v1

ESR1 mutations in metastatic lobular breast cancer patients

Christine Desmedt , Julien Pingitore , Françoise Rothé , Caterina Marchio , Florian Clatot
npj Breast Cancer, 2019, 5 (1), ⟨10.1038/s41523-019-0104-z⟩
Journal articles hal-02352890v1
Image document

Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

Maud Toulmonde , Marina Pulido , Isabelle Ray-Coquard , Thierry André , Nicolas Isambert
Lancet Oncology, 2019, 20 (9), pp.1263-1272. ⟨10.1016/S1470-2045(19)30276-1⟩
Journal articles hal-02533355v1
Image document

Surgery in reference centers improves survival of sarcoma patients: a nationwide study

J.-Y. Blay , C. Honore , E. Stoeckle , P. Méeus , M. Jafari
Annals of Oncology, 2019, Annals of oncology official journal of the European Society for Medical Oncology, 30 (7), pp.1143-1153. ⟨10.1093/annonc/mdz124⟩
Journal articles hal-02509515v1

Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response

Jessica Roelands , Wouter Hendrickx , Gabriele Zoppoli , Raghvendra Mall , Mohamad Saad
Journal for Immunotherapy of Cancer, 2019, 8 (1), pp.e000617. ⟨10.1136/jitc-2020-000617⟩
Journal articles hal-03623675v1
Image document

Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years

Clémence Basse , Antoine Italiano , Nicolas Penel , Olivier Mir , Claire Chemin
International Journal of Cancer, 2019, 145 (8), pp.2135-2143. ⟨10.1002/ijc.32307⟩
Journal articles hal-02504786v1
Image document

Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on “Cancer outside the Hospital Walls”

François Bertucci , Anne-Gaëlle Le Corroller-Soriano , Audrey Monneur-Miramon , Jean-François Moulin , Sylvain Fluzin
Cancers, 2019, 11 (2), pp.219. ⟨10.3390/cancers11020219⟩
Journal articles inserm-02329449v1

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

Yi Xiao , Ding Ma , Shen Zhao , Chen Suo , Jinxiu Shi
Clinical Cancer Research, 2019, 25 (16), pp.5002-5014. ⟨10.1158/1078-0432.CCR-18-3524⟩
Journal articles hal-02533431v1
Image document

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation

Sylvain Garciaz , Lia N’guyen Dasi , Pascal Finetti , Christine Chevalier , Julien Vernerey
Clinical Epigenetics, 2019, 11 (1), ⟨10.1186/s13148-019-0738-6⟩
Journal articles hal-02322283v1

A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine

L. Seguin , M. Chaffanet , R. Sabatier , A. Jose , S. Garnier
Annals of Oncology, 2018, 29 (6), ⟨10.1093/annonc/mdy314.030⟩
Journal articles hal-02143656v1

Determinants of favorable or unfavorable opinion about euthanasia in a sample of French cancer patients receiving palliative care

Alexandre de Nonneville , François Bertucci , Pascal Finetti , D. Perrot , M. Nilbert
BMC Palliative Care, 2018, 17 (1), pp.104. ⟨10.1186/s12904-018-0357-6⟩
Journal articles hal-03583406v1
Image document

Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value

Raoudha Doghri , Maroua Manai , Pascal Finetti , Maha Driss , Emilie Agavnian
International Journal of Molecular Sciences, 2018, 19 (1), ⟨10.3390/ijms19010041⟩
Journal articles hal-02143620v1
Image document

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer

Mathilde Guérin , Anthony Gonçalves , Yves Toiron , Emilie Baudelet , Matthieu Pophillat
Oncotarget, 2018, 9 (73), pp.33762-33777. ⟨10.18632/oncotarget.26031⟩
Journal articles hal-02145636v1
Image document

The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/beta-Catenin Signaling

Leonor Lopez Almeida , Michael Sebbagh , Francois Bertucci , Pascal Finetti , Julien Wicinski
Stem Cell Reports, 2018, 11 (5), pp.1040-1050. ⟨10.1016/j.stemcr.2018.09.008⟩
Journal articles hal-02143631v1

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

Francois Bertucci , Pascal Finetti , Ines Simeone , Wouter Hendrickx , Ena Wang
Breast Cancer Research and Treatment, 2018, 119 (11), pp.1383-1391. ⟨10.1038/s41416-018-0309-1⟩
Journal articles hal-02143596v1

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma

Nuria Kotecki , Axel Le Cesne , Emmanuelle Tresch-Bruneel , Isabelle Ray-Coquard , Christine Chevreau
American Journal of Clinical Oncology, 2018, 41 (11), pp.1094-1100. ⟨10.1097/coc.0000000000000430⟩
Journal articles hal-03623697v1

Inflammatory breast cancer in 210�patients: A retrospective study on epidemiological, anatomo‑clinical features and therapeutic results

Maroua Manai , Pascal Finetti , Nesrine Mejri , Salma Athimni , Daniel Birnbaum
Molecular and Clinical Oncology, 2018, 10 (2), pp.223-230. ⟨10.3892/mco.2018.1773⟩
Journal articles hal-02530356v1
Image document

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer

Renaud Sabatier , Véronique Diéras , Xavier B. Pivot , Etienne Brain , Henri Roche
Breast Cancer Research and Treatment, 2018, 50 (4), pp.1226-1237. ⟨10.4143/crt.2017.446⟩
Journal articles inserm-01985845v1

Reversible rituximab-induced rectal Kaposi's sarcoma misdiagnosed as ulcerative colitis in a patient with HIV-negative follicular lymphoma

Emilien Billon , Anne-Marie Stoppa , Lena Mescam , Massimo Bocci , Audrey Monneur
CLINICAL SARCOMA RESEARCH, 2018, 8, ⟨10.1186/s13569-018-0097-7⟩
Journal articles hal-02143666v1

Ex vivo CSC assays for personalized testing of drug susceptibility in advanced breast cancer

Emmanuelle Charafe-Jauffret , Julien Wicinski , Olivier Cabaud , Marc Lopez , Stephane Audebert
Cancer Research, 2018, 78 (4, S)
Journal articles hal-02143678v1

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib

Olivier Bouché , Axel Le Cesne , Maria Rios , Loic Chaigneau , Antoine Italiano
PLoS ONE, 2018, 13 (9), pp.e0204117. ⟨10.1371/journal.pone.0204117⟩
Journal articles hal-02005925v1

Giant Pedunculated Hepatic Hemangioma: A Case Report and Literature Review

Abdallah  Al farai , Lénaïg Mescam , Valeria De luca , Audrey Monneur , Delphine Perrot
Case Reports in Oncology, 2018, 11 (2), pp.476-484. ⟨10.1159/000490696⟩
Journal articles hal-03623704v1

Metastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review

Marie Cantaloube , Laurence Moureau-Zabotto , Lena Mescam , Audrey Monneur , Valeria Deluca
Case Reports in Oncology, 2018, 11 (1), pp.21-28. ⟨10.1159/000485740⟩
Journal articles hal-02143619v1

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy

Raoudha Boughzala-Bennadji , Eberhard Stoeckle , Cécile Le Péchoux , Pierre Méeus , Charles Honoré
International Journal of Radiation Oncology, Biology, Physics, 2018, 102 (2), pp.399-406. ⟨10.1016/j.ijrobp.2018.05.055⟩
Journal articles hal-02049039v1

The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma

F Bertucci , A de Nonneville , P Finetti , D Perrot , M Nilbert
Annals of Oncology, 2018, 29 (2), pp.459 - 465. ⟨10.1093/annonc/mdx699⟩
Journal articles hal-01787485v1

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Christine Desmedt , Roberto Salgado , Marco Fornili , Giancarlo Pruneri , Gert van den Eynden
European Journal of Cancer, 2018, 99 (7), pp.28-36. ⟨10.1016/j.ejca.2018.05.008⟩
Journal articles hal-03623702v1

CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors

Emilie Mamessier , David Birnbaum , Pascal Finetti , Daniel Birnbaum , François Bertucci
Annals of translational medicine, 2018, 6 (3), pp.54 - 54. ⟨10.21037/atm.2017.11.26⟩
Journal articles hal-01765411v1

PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer

Audrey Monneur , Anthony Goncalves , Francois Bertucci
Bulletin du Cancer, 2018, 105 (3), pp.261-272. ⟨10.1016/j.bulcan.2017.11.012⟩
Journal articles hal-02143676v1
Image document

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

Loïc Lebellec , François Bertucci , Emmanuelle Tresch-Bruneel , Isabelle Ray-Coquard , Axel Le Cesne
BMC Cancer, 2018, 18 (1), pp.963. ⟨10.1186/s12885-018-4828-1⟩
Journal articles inserm-02050851v1
Image document

Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

Emanuel Nicolas , François Bertucci , Renaud Sabatier , Anthony Gonçalves
Cancers, 2018, 10 (12), pp.506. ⟨10.3390/cancers10120506⟩
Journal articles hal-03669695v1

Poly (ADP-Ribose) Polymerase Inhibitors for De Novo BRCA2-Null Small-Cell Prostate Cancer

Brice Chanez , Max Chaffanet , José Adélaide , Jeanne Thomassin , Séverine Garnier
JCO precision oncology, 2018, 2, pp.1-8. ⟨10.1200/po.18.00083⟩
Journal articles hal-03623699v1

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer

David Birnbaum , François Bertucci , Pascal Finetti , Daniel Birnbaum , Emilie Mamessier
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2018, 1869 (2), pp.248-255. ⟨10.1016/j.bbcan.2018.02.001⟩
Journal articles hal-03583468v1

CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors

Luc Xerri , José Adelaïde , Cornel Popovici , Séverine Garnier , Arnaud Guille
American Journal of Surgical Pathology, 2018, 42 (2), pp.150 - 159. ⟨10.1097/PAS.0000000000000989⟩
Journal articles hal-01788565v1
Image document

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype

Kenichi Harano , Ying Wang , Bora Lim , Robert S. Seitz , Stephan W. Morris
PLoS ONE, 2018, 13 (10), pp.e0204513. ⟨10.1371/journal.pone.0204513⟩
Journal articles hal-02143557v1

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

François Bertucci , Pascal Finetti , Ines Simeone , Wouter Hendrickx , Ena Wang
British Journal of Cancer, 2018, 119 (11), pp.1383-1391. ⟨10.1038/s41416-018-0309-1⟩
Journal articles hal-03606514v1

``Wnt/beta-Catenin in GIST''-Letter

Francois Bertucci , Pascal Finetti , Alexandre de Nonneville , Daniel Birnbaum
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (1), pp.327-328. ⟨10.1158/1535-7163.MCT-17-0948⟩
Journal articles hal-02143618v1
Image document

Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

Emanuel Nicolas , Francois Bertucci , Renaud Sabatier , Anthony Goncalves
Cancers, 2018, 10 (12), ⟨10.3390/cancers10120506⟩
Journal articles hal-02143625v1
Image document

Circulating Tumour Cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab

Jean-Yves Pierga , François-Clément Bidard , A. Autret , Tillys Petit , Frédéric André
Annals of Oncology, 2017, 28, pp.mdw535. ⟨10.1093/annonc/mdw535⟩
Journal articles inserm-01985299v1

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

Anthony Gonçalves , Audrey Monneur , Patrice Viens , François Bertucci
Expert Review of Anticancer Therapy, 2017, 17 (7), pp.593-606. ⟨10.1080/14737140.2017.1330655⟩
Journal articles hal-03623715v1
Image document

Validation and comparison of the molecular classifications of pancreatic carcinomas

David Birnbaum , Pascal Finetti , Daniel Birnbaum , Emilie Mamessier , François Bertucci
Molecular Cancer, 2017, 16 (1), pp.168. ⟨10.1186/s12943-017-0739-z⟩
Journal articles hal-03583469v1
Image document

Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis

Wouter Hendrickx , Ines Simeone , Samreen Anjum , Younes Mokrab , François Bertucci
OncoImmunology, 2017, 6 (2), ⟨10.1080/2162402X.2016.1253654⟩
Journal articles hal-01788951v1

[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].

Laurys Boudin , Christian Chabannon , Patrick Sfumato , Renaud Sabatier , François Bertucci
Bulletin du Cancer, 2017, 104 (4), pp.332 - 343. ⟨10.1016/j.bulcan.2016.12.007⟩
Journal articles hal-01788977v1
Image document

MARCKS protein overexpression in inflammatory breast cancer

Maroua Manai , Jeanne Thomassin-Piana , Amor Gamoudi , Pascal Finetti , Marc Lopez
Oncotarget, 2017, 8, pp.6246 - 6257. ⟨10.18632/oncotarget.14057⟩
Journal articles hal-01787705v1

An ICGC major achievement in breast cancer: a comprehensive catalog of mutations and mutational signatures

François Bertucci , Max Chaffanet , Daniel Birnbaum
Chinese Clinical Oncology, 2017, 6 (1), pp.4 - 4. ⟨10.21037/cco.2016.11.01⟩
Journal articles hal-01787356v1

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

Preeti Putcha , Jiyang Yu , Ruth Rodriguez-Barrueco , Laura Saucedo-Cuevas , Patricia Villagrasa
Breast Cancer Research, 2017, 19 (1), pp.49. ⟨10.1186/s13058-017-0841-6⟩
Journal articles hal-03623716v1

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

Nicolas Penel , Axel Le Cesne , Sylvie Bonvalot , Antoine Giraud , Emmanuelle Bompas
European Journal of Cancer, 2017, 83, pp.125-131. ⟨10.1016/j.ejca.2017.06.017⟩
Journal articles hal-03623713v1
Image document

Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)

Madhura Joglekar-Javadekar , Steven van Laere , Michael Bourne , Manal Moalwi , Pascal Finetti
Neoplasia, 2017, 19 (7), pp.564-573. ⟨10.1016/j.neo.2017.03.002⟩
Journal articles hal-01789694v1
Image document

A retrospective multicentric study of ewing sarcoma family of tumors in patients older than 50: management and outcome

Pauline Rochefort , Antoine Italiano , Valérie Laurence , Nicolas Penel , Audrey Lardy-Cleaud
Scientific Reports, 2017, Scientific reports, 7, ⟨10.1038/s41598-017-17733-z⟩
Journal articles hal-02613645v1

A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study

Brice Chanez , François Bertucci , Marine Gilabert , Anne Madroszyk , Frédérique Rousseau
Supportive Care in Cancer, 2017, 25 (9), pp.2715-2722. ⟨10.1007/s00520-017-3680-1⟩
Journal articles hal-03623718v1
Image document

Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis

Vincent Berry , Laurent Basson , Emilie Bogart , Olivier Mir , Jean-Yves Blay
Cancer, 2017, Cancer, 123, pp.2294-2302. ⟨10.1002/cncr.30661⟩
Journal articles hal-02638646v1

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)

Loïc Lebellec , Bruno Chauffert , Jean-Yves Blay , Axel Le Cesne , Christine Chevreau
European Journal of Cancer, 2017, 79, pp.119 - 128. ⟨10.1016/j.ejca.2017.03.037⟩
Journal articles hal-01655981v1
Image document

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers

Audrey Monneur , Anthony Gonçalves , Marine Gilabert , Pascal Finetti , Carole Tarpin
Oncotarget, 2017, 8 (39), pp.66019 - 66032. ⟨10.18632/oncotarget.19732⟩
Journal articles inserm-01984755v1

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study

Alexandre de Nonneville , Anthony Gonçalves , Christophe Zemmour , Jean Classe , Monique Cohen
Breast Cancer Research and Treatment, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩
Journal articles hal-03623719v1

Scientific summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) program 10th Anniversary Conference

Wendy Woodward , Massimo Cristofanilli , Sofia Merajver , Steven van Laere , Lajos Pusztai
Journal of Cancer, 2017, 8 (17), pp.3607-3614. ⟨10.7150/jca.21200⟩
Journal articles hal-03623708v1

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer

Mathilde Guerin , Keyvan Rezai , Nicolas Isambert , Mario Campone , Aurélie Autret
European Journal of Cancer, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
Journal articles hal-03623711v1
Image document

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

M. M-Rabet , O. Cabaud , E. Josselin , P. Finetti , R. Castellano
Annals of Oncology, 2017, ⟨10.1093/annonc/mdw678⟩
Journal articles hal-01787533v1

Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study

A. de Nonneville , A. Goncalves , C. Zemmour , M. Cohen , J.M. Classe
European Journal of Cancer, 2017, 84, pp.34-43. ⟨10.1016/j.ejca.2017.06.043⟩
Journal articles hal-02282824v1

Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1

François Bertucci , Anthony Gonçalves
Current Oncology Reports, 2017, 19 (10), pp.64. ⟨10.1007/s11912-017-0627-0⟩
Journal articles hal-03623712v1
Image document

Nectine-4 : un biomarqueur pronostique et une cible thérapeutique potentielle dans le cancer du sein triple-négatif

Manel M 'Rabet , François Bertucci , Daniel Birnbaum , Marc Lopez
Médecine/Sciences, 2017
Journal articles hal-01788721v1

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas

François Bertucci , Pascal Finetti , Delphine Perrot , Agnès Leroux , Françoise Collin
OncoImmunology, 2017, 6 (3), pp.e1278100. ⟨10.1080/2162402X.2016.1278100⟩
Journal articles hal-01765418v1
Image document

miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy

Ruth Rodriguez-Barrueco , Erin A Nekritz , François Bertucci , Jiyang Yu , Felix Sanchez-Garcia
Genes and Development, 2017, 31 (6), pp.553-566. ⟨10.1101/gad.292318.116⟩
Journal articles hal-01787959v1

A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability

Anne Morel , Christophe Ginestier , Roxane Pommier , Olivier Cabaud , Emmanuelle Ruiz
Nature Medicine, 2017, 23 (5), pp.568 - 578. ⟨10.1038/nm.4323⟩
Journal articles hal-01788395v1

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

S. Salas , N. Resseguier , Jean-Yves Blay , A. Le Cesne , A. Italiano
Annals of Oncology, 2017, 28 (8), pp.1979 - 1987. ⟨10.1093/annonc/mdx250⟩
Journal articles hal-01655970v1
Image document

miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling

Rita El Helou , Guillaume Pinna , Olivier Cabaud , Julien Wicinski , Ricky Bhajun
Cell Reports, 2017, 18 (9), pp.2256-2268. ⟨10.1016/j.celrep.2017.02.016⟩
Journal articles hal-01789620v1

Prognostic Value of Molecular Subtypes in Pancreatic Cancer

François Bertucci , David Birnbaum , Pascal Finetti , Marine Gilabert , Flora Poizat
Pancreas, 2017, 46 (4), pp.e29-e31. ⟨10.1097/MPA.0000000000000787⟩
Journal articles hal-03606452v1
Image document

A 25-gene classifier predicts overall survival in resectable pancreatic cancer

David Birnbaum , Pascal Finetti , Alexia Lopresti , Marine Gilabert , Flora Poizat
BMC Medicine, 2017, 15 (1), ⟨10.1186/s12916-017-0936-z⟩
Journal articles hal-01787872v1

Wnt Signaling Inhibition Promotes Apoptosis in Sarcomas—Letter

François Bertucci , Pascal Finetti , Daniel Birnbaum
Molecular Cancer Therapeutics, 2017, 16 (10), pp.2324 - 2324. ⟨10.1158/1535-7163.MCT-17-0491⟩
Journal articles hal-01787271v1

Gastrointestinal Stromal Tumour with Synchronous Bone Metastases: A Case Report and Literature Review

Philippe Rochigneux , Lénaig Mescam-Mancini , Delphine Perrot , Erwan Bories , Laurence Moureau-Zabotto
Case Reports in Oncology, 2017, 10 (1), pp.66-76. ⟨10.1159/000455188⟩
Journal articles hal-03623722v1

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study

François Bertucci , Mahmoud Fekih , Aurélie Autret , Thierry Petit , Florence Dalenc
Lancet Oncology, 2016, 17 (5), pp.600-611. ⟨10.1016/s1470-2045(16)00011-5⟩
Journal articles hal-03623735v1

Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126]

Laurys Boudin , Christian Chabannon , Patrick Sfumato , Renaud Sabatier , François Bertucci
European Journal of Cancer, 2016, 67, pp.223. ⟨10.1016/j.ejca.2016.09.002⟩
Journal articles hal-03623727v1

Molecular targeted therapies (MTT) in advanced chordoma (AC) patients (pts).

Loic Lebellec , Axel Le Cesne , Nicolas Penel , Jean -Yves Blay , Christine Chevreau
Journal of Clinical Oncology, 2016, 34 (15, S), ⟨10.1200/JCO.2016.34.15\_suppl.11020⟩
Journal articles hal-03598684v1

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

A. Patrikidou , J. Domont , Sylvie Chabaud , Isabelle Ray-Coquard , J.M. Coindre
European Journal of Cancer, 2016, 52, pp.173--180. ⟨10.1016/j.ejca.2015.10.069⟩
Journal articles hal-01812685v1

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study

Anthony Gonçalves , François Bertucci , Arnaud Guille , Severine Garnier , José Adelaide
Oncotarget, 2016, 7 (48), pp.79428-79441. ⟨10.18632/oncotarget.12714⟩
Journal articles hal-03623724v1

Genomic Characterization of Primary Invasive Lobular Breast Cancer

Christine Desmedt , Gabriele Zoppoli , Gunes Gundem , Giancarlo Pruneri , Denis Larsimont
Journal of Clinical Oncology, 2016, 34 (16), pp.1872-1881. ⟨10.1200/jco.2015.64.0334⟩
Journal articles hal-03623737v1

XPO1, therapeutic...and prognostic target in sarcomas

François Bertucci , Pascal Finetti , Daniel Birnbaum
Oncoscience, 2016, 3 (5-6), pp.143-144. ⟨10.18632/oncoscience.304⟩
Journal articles hal-03623732v1

SPAG5: the ultimate marker of proliferation in early breast cancer?

François Bertucci , Patrice Viens , Daniel Birnbaum
Lancet Oncology, 2016, 17 (7), pp.863-865. ⟨10.1016/s1470-2045(16)30092-4⟩
Journal articles hal-03623730v1
Image document

Prognostic value of PDL1 expression in pancreatic cancer

David Birnbaum , Pascal Finetti , Alexia Lopresti , Marine Gilabert , Flora Poizat
Oncotarget, 2016, 7 (44), ⟨10.18632/oncotarget.11685⟩
Journal articles hal-01765421v1
Image document

Pregnane X-receptor promotes stem cell-mediated colon cancer relapse

Chris Planque , Fatemeh Rajabi , Fanny Grillet , Pascal Finetti , François Bertucci
Oncotarget, 2016, 7 (35), pp.56558-56573. ⟨10.18632/oncotarget.10646⟩
Journal articles hal-01431926v1

Prognostic value of PDL1 expression in pancreatic cancer

David Birnbaum , Pascal Finetti , Alexia Lopresti , Marine Gilabert , Flora Poizat
Oncotarget, 2016, 7 (44), pp.71198-71210. ⟨10.18632/oncotarget.11685⟩
Journal articles hal-03583475v1

Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem-like Cells

Julie Giraud , Laura Failla , Jean-Marc Pascussi , Ebba Louise Lagerqvist , Jérémy Ollier
Cancer Research, 2016, 76 (12), pp.3618 - 3628. ⟨10.1158/0008-5472.CAN-15-1497⟩
Journal articles hal-01905320v1
Image document

Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma.

David Birnbaum , François Bertucci , Pascal Finetti , José Adélaïde , Marc Giovannini
Cancer Genomics and Proteomics, 2016, 13 (3), pp.191-200
Journal articles hal-03583479v1

Bevacizumab in HER2-negative inflammatory breast cancer

François Bertucci , Anthony Goncalves , Patrice Viens
Oncoscience, 2016, 3 (11-12), pp.297-298. ⟨10.18632/oncoscience.324⟩
Journal articles hal-03623723v1

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial

Olivier Mir , Claire Cropet , Maud Toulmonde , Axel Le Cesne , Mathieu Molimard
Lancet Oncology, 2016, 17 (5), pp.632-641. ⟨10.1016/s1470-2045(16)00075-9⟩
Journal articles hal-03623734v1

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study

Emeline Tabouret , François Bertucci , Jean-Yves Pierga , Thierry Petit , Christelle Levy
Oncotarget, 2016, 7 (14), pp.18531-18540. ⟨10.18632/oncotarget.7612⟩
Journal articles hal-03623733v1

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

N. Penel , J.M. Coindre , S. Bonvalot , A. Italiano , A. Neuville
European Journal of Cancer, 2016, 58, pp.90--96. ⟨10.1016/j.ejca.2016.02.008⟩
Journal articles hal-01812682v1
Image document

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study

Laurys Boudin , Anthony Gonçalves , Patrick Sfumato , Renaud Sabatier , François Bertucci
American Journal of Cancer, 2016, 7 (14), pp.2077-2084. ⟨10.7150/jca.15797⟩
Journal articles inserm-01987531v1

Comparative genomic analysis of primary tumors and metastases in breast cancer

François Bertucci , Pascal Finetti , Arnaud Guille , José Adélaïde , Séverine Garnier
Oncotarget, 2016, 7 (19), pp.27208-27219. ⟨10.18632/oncotarget.8349⟩
Journal articles hal-03623731v1

PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progression

Christelle Vincent-Fabert , Nadine Platet , Amelle Vandevelde , Mathilde Poplineau , Myriam Koubi
Blood, 2016, 127 (15), pp.1881-1885. ⟨10.1182/blood-2015-09-666974⟩
Journal articles hal-03623736v1
Image document

Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer

Tania M. Puvirajesinghe , François Bertucci , Ashish Jain , Pierluigi Scerbo , Edwige Belotti
Nature Communications, 2016, 7, pp.10318. ⟨10.1038/ncomms10318⟩
Journal articles hal-01447570v1
Image document

PRICKLE1 contributes to cancer cell dissemination through its interaction with mTORC2

Avais M Daulat , François Bertucci , Stéphane Audebert , Arnauld Sergé , Pascal Finetti
Developmental Cell, 2016, 37, pp.311-325. ⟨10.1016/j.devcel.2016.04.011⟩
Journal articles hal-01321061v1

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

Olivier Mir , Thomas Brodowicz , Antoine Itali